Global CRO in Clinical Trials Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 85

Published Date: 18 Mar 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries.

Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others.

In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor’s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).

According to our (Global Info Research) latest study, the global CRO in Clinical Trials market size was valued at USD 44220 million in 2022 and is forecast to a readjusted size of USD 81210 million by 2029 with a CAGR of 9.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global core CRO in clinical trials players include Labcorp, IQVIA and Parexel etc. The top 5 companies hold a share about 40%. North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 35% and 20%.

In terms of product, phase iii trial is the largest segment, with a share about 35%. And in terms ofend users, the largest end user is pharmaceutical，with a share about 55%.

This report is a detailed and comprehensive analysis for global CRO in Clinical Trials market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global CRO in Clinical Trials market size and forecasts, in consumption value ($ Million), 2018-2029
Global CRO in Clinical Trials market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global CRO in Clinical Trials market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global CRO in Clinical Trials market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CRO in Clinical Trials
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CRO in Clinical Trials market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Labcorp, IQVIA, Parexel, Syneos Health and PRA Health Sciences, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
CRO in Clinical Trials market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Phase I Trial
    Phase II Trial
    Phase III Trial
    Phase IV Trial

Market segment by Application
    Pharmaceutical
    Bio-pharm
    Others

Market segment by players, this report covers
    Labcorp
    IQVIA
    Parexel
    Syneos Health
    PRA Health Sciences
    PPD
    ICON
    MedPace
    Wuxi AppTec

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CRO in Clinical Trials product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CRO in Clinical Trials, with revenue, gross margin and global market share of CRO in Clinical Trials from 2018 to 2023.
Chapter 3, the CRO in Clinical Trials competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and CRO in Clinical Trials market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of CRO in Clinical Trials.
Chapter 13, to describe CRO in Clinical Trials research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of CRO in Clinical Trials
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of CRO in Clinical Trials by Type
        1.3.1 Overview: Global CRO in Clinical Trials Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global CRO in Clinical Trials Consumption Value Market Share by Type in 2022
        1.3.3 Phase I Trial
        1.3.4 Phase II Trial
        1.3.5 Phase III Trial
        1.3.6 Phase IV Trial
    1.4 Global CRO in Clinical Trials Market by Application
        1.4.1 Overview: Global CRO in Clinical Trials Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pharmaceutical
        1.4.3 Bio-pharm
        1.4.4 Others
    1.5 Global CRO in Clinical Trials Market Size & Forecast
    1.6 Global CRO in Clinical Trials Market Size and Forecast by Region
        1.6.1 Global CRO in Clinical Trials Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global CRO in Clinical Trials Market Size by Region, (2018-2029)
        1.6.3 North America CRO in Clinical Trials Market Size and Prospect (2018-2029)
        1.6.4 Europe CRO in Clinical Trials Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific CRO in Clinical Trials Market Size and Prospect (2018-2029)
        1.6.6 South America CRO in Clinical Trials Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa CRO in Clinical Trials Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Labcorp
        2.1.1 Labcorp Details
        2.1.2 Labcorp Major Business
        2.1.3 Labcorp CRO in Clinical Trials Product and Solutions
        2.1.4 Labcorp CRO in Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Labcorp Recent Developments and Future Plans
    2.2 IQVIA
        2.2.1 IQVIA Details
        2.2.2 IQVIA Major Business
        2.2.3 IQVIA CRO in Clinical Trials Product and Solutions
        2.2.4 IQVIA CRO in Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 IQVIA Recent Developments and Future Plans
    2.3 Parexel
        2.3.1 Parexel Details
        2.3.2 Parexel Major Business
        2.3.3 Parexel CRO in Clinical Trials Product and Solutions
        2.3.4 Parexel CRO in Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Parexel Recent Developments and Future Plans
    2.4 Syneos Health
        2.4.1 Syneos Health Details
        2.4.2 Syneos Health Major Business
        2.4.3 Syneos Health CRO in Clinical Trials Product and Solutions
        2.4.4 Syneos Health CRO in Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Syneos Health Recent Developments and Future Plans
    2.5 PRA Health Sciences
        2.5.1 PRA Health Sciences Details
        2.5.2 PRA Health Sciences Major Business
        2.5.3 PRA Health Sciences CRO in Clinical Trials Product and Solutions
        2.5.4 PRA Health Sciences CRO in Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 PRA Health Sciences Recent Developments and Future Plans
    2.6 PPD
        2.6.1 PPD Details
        2.6.2 PPD Major Business
        2.6.3 PPD CRO in Clinical Trials Product and Solutions
        2.6.4 PPD CRO in Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 PPD Recent Developments and Future Plans
    2.7 ICON
        2.7.1 ICON Details
        2.7.2 ICON Major Business
        2.7.3 ICON CRO in Clinical Trials Product and Solutions
        2.7.4 ICON CRO in Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 ICON Recent Developments and Future Plans
    2.8 MedPace
        2.8.1 MedPace Details
        2.8.2 MedPace Major Business
        2.8.3 MedPace CRO in Clinical Trials Product and Solutions
        2.8.4 MedPace CRO in Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 MedPace Recent Developments and Future Plans
    2.9 Wuxi AppTec
        2.9.1 Wuxi AppTec Details
        2.9.2 Wuxi AppTec Major Business
        2.9.3 Wuxi AppTec CRO in Clinical Trials Product and Solutions
        2.9.4 Wuxi AppTec CRO in Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Wuxi AppTec Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global CRO in Clinical Trials Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of CRO in Clinical Trials by Company Revenue
        3.2.2 Top 3 CRO in Clinical Trials Players Market Share in 2022
        3.2.3 Top 6 CRO in Clinical Trials Players Market Share in 2022
    3.3 CRO in Clinical Trials Market: Overall Company Footprint Analysis
        3.3.1 CRO in Clinical Trials Market: Region Footprint
        3.3.2 CRO in Clinical Trials Market: Company Product Type Footprint
        3.3.3 CRO in Clinical Trials Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global CRO in Clinical Trials Consumption Value and Market Share by Type (2018-2023)
    4.2 Global CRO in Clinical Trials Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global CRO in Clinical Trials Consumption Value Market Share by Application (2018-2023)
    5.2 Global CRO in Clinical Trials Market Forecast by Application (2024-2029)

6 North America
    6.1 North America CRO in Clinical Trials Consumption Value by Type (2018-2029)
    6.2 North America CRO in Clinical Trials Consumption Value by Application (2018-2029)
    6.3 North America CRO in Clinical Trials Market Size by Country
        6.3.1 North America CRO in Clinical Trials Consumption Value by Country (2018-2029)
        6.3.2 United States CRO in Clinical Trials Market Size and Forecast (2018-2029)
        6.3.3 Canada CRO in Clinical Trials Market Size and Forecast (2018-2029)
        6.3.4 Mexico CRO in Clinical Trials Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe CRO in Clinical Trials Consumption Value by Type (2018-2029)
    7.2 Europe CRO in Clinical Trials Consumption Value by Application (2018-2029)
    7.3 Europe CRO in Clinical Trials Market Size by Country
        7.3.1 Europe CRO in Clinical Trials Consumption Value by Country (2018-2029)
        7.3.2 Germany CRO in Clinical Trials Market Size and Forecast (2018-2029)
        7.3.3 France CRO in Clinical Trials Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom CRO in Clinical Trials Market Size and Forecast (2018-2029)
        7.3.5 Russia CRO in Clinical Trials Market Size and Forecast (2018-2029)
        7.3.6 Italy CRO in Clinical Trials Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific CRO in Clinical Trials Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific CRO in Clinical Trials Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific CRO in Clinical Trials Market Size by Region
        8.3.1 Asia-Pacific CRO in Clinical Trials Consumption Value by Region (2018-2029)
        8.3.2 China CRO in Clinical Trials Market Size and Forecast (2018-2029)
        8.3.3 Japan CRO in Clinical Trials Market Size and Forecast (2018-2029)
        8.3.4 South Korea CRO in Clinical Trials Market Size and Forecast (2018-2029)
        8.3.5 India CRO in Clinical Trials Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia CRO in Clinical Trials Market Size and Forecast (2018-2029)
        8.3.7 Australia CRO in Clinical Trials Market Size and Forecast (2018-2029)

9 South America
    9.1 South America CRO in Clinical Trials Consumption Value by Type (2018-2029)
    9.2 South America CRO in Clinical Trials Consumption Value by Application (2018-2029)
    9.3 South America CRO in Clinical Trials Market Size by Country
        9.3.1 South America CRO in Clinical Trials Consumption Value by Country (2018-2029)
        9.3.2 Brazil CRO in Clinical Trials Market Size and Forecast (2018-2029)
        9.3.3 Argentina CRO in Clinical Trials Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa CRO in Clinical Trials Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa CRO in Clinical Trials Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa CRO in Clinical Trials Market Size by Country
        10.3.1 Middle East & Africa CRO in Clinical Trials Consumption Value by Country (2018-2029)
        10.3.2 Turkey CRO in Clinical Trials Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia CRO in Clinical Trials Market Size and Forecast (2018-2029)
        10.3.4 UAE CRO in Clinical Trials Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 CRO in Clinical Trials Market Drivers
    11.2 CRO in Clinical Trials Market Restraints
    11.3 CRO in Clinical Trials Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 CRO in Clinical Trials Industry Chain
    12.2 CRO in Clinical Trials Upstream Analysis
    12.3 CRO in Clinical Trials Midstream Analysis
    12.4 CRO in Clinical Trials Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global CRO in Clinical Trials Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global CRO in Clinical Trials Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global CRO in Clinical Trials Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global CRO in Clinical Trials Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Labcorp Company Information, Head Office, and Major Competitors
    Table 6. Labcorp Major Business
    Table 7. Labcorp CRO in Clinical Trials Product and Solutions
    Table 8. Labcorp CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Labcorp Recent Developments and Future Plans
    Table 10. IQVIA Company Information, Head Office, and Major Competitors
    Table 11. IQVIA Major Business
    Table 12. IQVIA CRO in Clinical Trials Product and Solutions
    Table 13. IQVIA CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. IQVIA Recent Developments and Future Plans
    Table 15. Parexel Company Information, Head Office, and Major Competitors
    Table 16. Parexel Major Business
    Table 17. Parexel CRO in Clinical Trials Product and Solutions
    Table 18. Parexel CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Parexel Recent Developments and Future Plans
    Table 20. Syneos Health Company Information, Head Office, and Major Competitors
    Table 21. Syneos Health Major Business
    Table 22. Syneos Health CRO in Clinical Trials Product and Solutions
    Table 23. Syneos Health CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Syneos Health Recent Developments and Future Plans
    Table 25. PRA Health Sciences Company Information, Head Office, and Major Competitors
    Table 26. PRA Health Sciences Major Business
    Table 27. PRA Health Sciences CRO in Clinical Trials Product and Solutions
    Table 28. PRA Health Sciences CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. PRA Health Sciences Recent Developments and Future Plans
    Table 30. PPD Company Information, Head Office, and Major Competitors
    Table 31. PPD Major Business
    Table 32. PPD CRO in Clinical Trials Product and Solutions
    Table 33. PPD CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. PPD Recent Developments and Future Plans
    Table 35. ICON Company Information, Head Office, and Major Competitors
    Table 36. ICON Major Business
    Table 37. ICON CRO in Clinical Trials Product and Solutions
    Table 38. ICON CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. ICON Recent Developments and Future Plans
    Table 40. MedPace Company Information, Head Office, and Major Competitors
    Table 41. MedPace Major Business
    Table 42. MedPace CRO in Clinical Trials Product and Solutions
    Table 43. MedPace CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. MedPace Recent Developments and Future Plans
    Table 45. Wuxi AppTec Company Information, Head Office, and Major Competitors
    Table 46. Wuxi AppTec Major Business
    Table 47. Wuxi AppTec CRO in Clinical Trials Product and Solutions
    Table 48. Wuxi AppTec CRO in Clinical Trials Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Wuxi AppTec Recent Developments and Future Plans
    Table 50. Global CRO in Clinical Trials Revenue (USD Million) by Players (2018-2023)
    Table 51. Global CRO in Clinical Trials Revenue Share by Players (2018-2023)
    Table 52. Breakdown of CRO in Clinical Trials by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 53. Market Position of Players in CRO in Clinical Trials, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 54. Head Office of Key CRO in Clinical Trials Players
    Table 55. CRO in Clinical Trials Market: Company Product Type Footprint
    Table 56. CRO in Clinical Trials Market: Company Product Application Footprint
    Table 57. CRO in Clinical Trials New Market Entrants and Barriers to Market Entry
    Table 58. CRO in Clinical Trials Mergers, Acquisition, Agreements, and Collaborations
    Table 59. Global CRO in Clinical Trials Consumption Value (USD Million) by Type (2018-2023)
    Table 60. Global CRO in Clinical Trials Consumption Value Share by Type (2018-2023)
    Table 61. Global CRO in Clinical Trials Consumption Value Forecast by Type (2024-2029)
    Table 62. Global CRO in Clinical Trials Consumption Value by Application (2018-2023)
    Table 63. Global CRO in Clinical Trials Consumption Value Forecast by Application (2024-2029)
    Table 64. North America CRO in Clinical Trials Consumption Value by Type (2018-2023) & (USD Million)
    Table 65. North America CRO in Clinical Trials Consumption Value by Type (2024-2029) & (USD Million)
    Table 66. North America CRO in Clinical Trials Consumption Value by Application (2018-2023) & (USD Million)
    Table 67. North America CRO in Clinical Trials Consumption Value by Application (2024-2029) & (USD Million)
    Table 68. North America CRO in Clinical Trials Consumption Value by Country (2018-2023) & (USD Million)
    Table 69. North America CRO in Clinical Trials Consumption Value by Country (2024-2029) & (USD Million)
    Table 70. Europe CRO in Clinical Trials Consumption Value by Type (2018-2023) & (USD Million)
    Table 71. Europe CRO in Clinical Trials Consumption Value by Type (2024-2029) & (USD Million)
    Table 72. Europe CRO in Clinical Trials Consumption Value by Application (2018-2023) & (USD Million)
    Table 73. Europe CRO in Clinical Trials Consumption Value by Application (2024-2029) & (USD Million)
    Table 74. Europe CRO in Clinical Trials Consumption Value by Country (2018-2023) & (USD Million)
    Table 75. Europe CRO in Clinical Trials Consumption Value by Country (2024-2029) & (USD Million)
    Table 76. Asia-Pacific CRO in Clinical Trials Consumption Value by Type (2018-2023) & (USD Million)
    Table 77. Asia-Pacific CRO in Clinical Trials Consumption Value by Type (2024-2029) & (USD Million)
    Table 78. Asia-Pacific CRO in Clinical Trials Consumption Value by Application (2018-2023) & (USD Million)
    Table 79. Asia-Pacific CRO in Clinical Trials Consumption Value by Application (2024-2029) & (USD Million)
    Table 80. Asia-Pacific CRO in Clinical Trials Consumption Value by Region (2018-2023) & (USD Million)
    Table 81. Asia-Pacific CRO in Clinical Trials Consumption Value by Region (2024-2029) & (USD Million)
    Table 82. South America CRO in Clinical Trials Consumption Value by Type (2018-2023) & (USD Million)
    Table 83. South America CRO in Clinical Trials Consumption Value by Type (2024-2029) & (USD Million)
    Table 84. South America CRO in Clinical Trials Consumption Value by Application (2018-2023) & (USD Million)
    Table 85. South America CRO in Clinical Trials Consumption Value by Application (2024-2029) & (USD Million)
    Table 86. South America CRO in Clinical Trials Consumption Value by Country (2018-2023) & (USD Million)
    Table 87. South America CRO in Clinical Trials Consumption Value by Country (2024-2029) & (USD Million)
    Table 88. Middle East & Africa CRO in Clinical Trials Consumption Value by Type (2018-2023) & (USD Million)
    Table 89. Middle East & Africa CRO in Clinical Trials Consumption Value by Type (2024-2029) & (USD Million)
    Table 90. Middle East & Africa CRO in Clinical Trials Consumption Value by Application (2018-2023) & (USD Million)
    Table 91. Middle East & Africa CRO in Clinical Trials Consumption Value by Application (2024-2029) & (USD Million)
    Table 92. Middle East & Africa CRO in Clinical Trials Consumption Value by Country (2018-2023) & (USD Million)
    Table 93. Middle East & Africa CRO in Clinical Trials Consumption Value by Country (2024-2029) & (USD Million)
    Table 94. CRO in Clinical Trials Raw Material
    Table 95. Key Suppliers of CRO in Clinical Trials Raw Materials
List of Figures
    Figure 1. CRO in Clinical Trials Picture
    Figure 2. Global CRO in Clinical Trials Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global CRO in Clinical Trials Consumption Value Market Share by Type in 2022
    Figure 4. Phase I Trial
    Figure 5. Phase II Trial
    Figure 6. Phase III Trial
    Figure 7. Phase IV Trial
    Figure 8. Global CRO in Clinical Trials Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. CRO in Clinical Trials Consumption Value Market Share by Application in 2022
    Figure 10. Pharmaceutical Picture
    Figure 11. Bio-pharm Picture
    Figure 12. Others Picture
    Figure 13. Global CRO in Clinical Trials Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global CRO in Clinical Trials Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Market CRO in Clinical Trials Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 16. Global CRO in Clinical Trials Consumption Value Market Share by Region (2018-2029)
    Figure 17. Global CRO in Clinical Trials Consumption Value Market Share by Region in 2022
    Figure 18. North America CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 20. Asia-Pacific CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 21. South America CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 22. Middle East and Africa CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 23. Global CRO in Clinical Trials Revenue Share by Players in 2022
    Figure 24. CRO in Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 25. Global Top 3 Players CRO in Clinical Trials Market Share in 2022
    Figure 26. Global Top 6 Players CRO in Clinical Trials Market Share in 2022
    Figure 27. Global CRO in Clinical Trials Consumption Value Share by Type (2018-2023)
    Figure 28. Global CRO in Clinical Trials Market Share Forecast by Type (2024-2029)
    Figure 29. Global CRO in Clinical Trials Consumption Value Share by Application (2018-2023)
    Figure 30. Global CRO in Clinical Trials Market Share Forecast by Application (2024-2029)
    Figure 31. North America CRO in Clinical Trials Consumption Value Market Share by Type (2018-2029)
    Figure 32. North America CRO in Clinical Trials Consumption Value Market Share by Application (2018-2029)
    Figure 33. North America CRO in Clinical Trials Consumption Value Market Share by Country (2018-2029)
    Figure 34. United States CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 35. Canada CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 36. Mexico CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 37. Europe CRO in Clinical Trials Consumption Value Market Share by Type (2018-2029)
    Figure 38. Europe CRO in Clinical Trials Consumption Value Market Share by Application (2018-2029)
    Figure 39. Europe CRO in Clinical Trials Consumption Value Market Share by Country (2018-2029)
    Figure 40. Germany CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 41. France CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 42. United Kingdom CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 43. Russia CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 44. Italy CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 45. Asia-Pacific CRO in Clinical Trials Consumption Value Market Share by Type (2018-2029)
    Figure 46. Asia-Pacific CRO in Clinical Trials Consumption Value Market Share by Application (2018-2029)
    Figure 47. Asia-Pacific CRO in Clinical Trials Consumption Value Market Share by Region (2018-2029)
    Figure 48. China CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 49. Japan CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 50. South Korea CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 51. India CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 52. Southeast Asia CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 53. Australia CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 54. South America CRO in Clinical Trials Consumption Value Market Share by Type (2018-2029)
    Figure 55. South America CRO in Clinical Trials Consumption Value Market Share by Application (2018-2029)
    Figure 56. South America CRO in Clinical Trials Consumption Value Market Share by Country (2018-2029)
    Figure 57. Brazil CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 58. Argentina CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 59. Middle East and Africa CRO in Clinical Trials Consumption Value Market Share by Type (2018-2029)
    Figure 60. Middle East and Africa CRO in Clinical Trials Consumption Value Market Share by Application (2018-2029)
    Figure 61. Middle East and Africa CRO in Clinical Trials Consumption Value Market Share by Country (2018-2029)
    Figure 62. Turkey CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 63. Saudi Arabia CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 64. UAE CRO in Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 65. CRO in Clinical Trials Market Drivers
    Figure 66. CRO in Clinical Trials Market Restraints
    Figure 67. CRO in Clinical Trials Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of CRO in Clinical Trials in 2022
    Figure 70. Manufacturing Process Analysis of CRO in Clinical Trials
    Figure 71. CRO in Clinical Trials Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global CRO in Clinical Trials Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global CRO in Clinical Trials Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 19 Nov 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global CRO in Clinical Trials market size was valued at US$ 48580 million in 2023 and is forecast to a readjusted size of USD 89680 million by 2030 with a CAGR of 9.3% during review period.

Global CRO in Clinical Trials Supply, Demand and Key Producers, 2024-2030

Global CRO in Clinical Trials Supply, Demand and Key Producers, 2024-2030

date 19 Nov 2024

date Medical Devices & Consumables

The global CRO in Clinical Trials market size is expected to reach $ 89680 million by 2030, rising at a market growth of 9.3% CAGR during the forecast period (2024-2030).

Product Tags

CRO in Clinical Trials

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>